Search
Innovative Drug Stocks Soar Against Market Trend, Thalys Medical Hits Daily Limit
2025-07-01 /
Read about 0 minute
Author：小编
The National Healthcare Security Administration recently held a press conference to unveil 16 initiatives aimed at fostering the high-quality development of innovative drugs. These measures encompass bolstering R&D support, refining access policies, and introducing a catalog of innovative drugs covered by commercial insurance. Reacting positively to this news, Thalys Medical shares surged to their daily limit, while several other pharmaceutical stocks, including Rongchang Biologics and STaidson Biopharmaceuticals, witnessed gains exceeding 5%. Additionally, Hanyu Pharmaceutical and Joyance Pharmaceutical also recorded notable upticks.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
